The Alliance for Regenerative Medicine Elects Edward

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The Alliance for Regenerative Medicine Elects Edward Lanphier as Chairman, Welcomes New Officers and Executive Committee Members

WASHINGTON, Nov. 10, 2014 (GLOBE NEWSWIRE) -- via PRWEB - The Alliance for Regenerative Medicine (ARM), the international organization representing the regenerative medicine and advanced therapies community, announces the election of Edward Lanphier, Founder, President and Chief Executive Officer (CEO) of Sangamo BioSciences (NASDAQ: SGMO), as its next Chairman. Robert Preti, Ph.D., Co-founder, President and Chief Scientific Officer (CSO) of Progenitor Cell Therapy (PCT) and CSO of NeoStem, has been named Vice-Chairman. Claudia Zylberberg, Ph.D., CEO of Akron Biotech, was elected as Treasurer and Phil Vanek, Ph.D., General Manager Cell BioProcessing at GE Healthcare, was elected Secretary. Mr. Lanphier will replace Geoff MacKay, President and CEO of Organogenesis Inc., who will complete his two-year term as Chairman on December 31, 2014.

"During his term as Chairman, Geoff oversaw record membership growth as well as the creation of ARM's three technology sections for cell therapy, gene and gene-modified cell therapy and tissue engineering and biomaterials. He was also involved in the formation of the organization's European Section, a result of a membership merger with the former Alliance for Advanced Therapies. We thank him for his tireless leadership and efforts to advance both ARM and the rapidly evolving field of regenerative medicine, and are pleased he has agreed to remain on in an ex-officio capacity going forward," said Michael Werner, Executive Director of ARM. "With the election of Edward, ARM's chairmanship now passes to one of the most experienced and respected CEOs in the advanced therapies and regenerative medicine sector. He's the right leader at the right time as ARM enters its next phase of influence and growth," added Morrie Ruffin, Managing Director of ARM.

"ARM has made tremendous progress in the five years since its inception, and I am honored to be elected Chairman of what has become the leading organization representing the gene and cell therapies sector. I look forward to building upon the work that Geoff and the others who have come before me have initiated, and to leading the organization during such an important juncture for our field," said Mr. Lanphier. "During my term, I hope to continue the expansion ARM has recently experienced and further accelerate progress of these important products, ensuring these technologies achieve their potential and rapidly reach patients in need."

In addition to the officers, the other elected members of the 2015 ARM Executive Committee include:

  • Rahul Aras, Ph.D., President and CEO, Juventas Therapeutics
  • Eduardo Bravo, Managing Director and CEO, TiGenix NV
  • Lucie Bruijn, Ph.D., Chief Scientist, The ALS Association
  • Douglas Doerfler, President and CEO, MaxCyte
  • Flagg Flanagan, Chairman and CEO, DiscGenics
  • Douglas Kerr, M.D., Ph.D., Senior Medical Director, Clinical Development, Biogen Idec
  • Perry Karsen, CEO, Celgene Cellular Therapeutics
  • Dena Ladd, Executive Director, Missouri Cures
  • Geoff MacKay, President and CEO, Organogenesis Inc. (ex-officio)
  • Michael May, Ph.D., CEO, Centre for Commercialization of Regenerative Medicine (CCRM)
  • C. Randal Mills, Ph.D., President, California Institute for Regenerative Medicine (CIRM)
  • Martin McGlynn, President and CEO, StemCells, Inc.
  • Keith Murphy, Chairman and CEO, Organovo
  • Bernard Siegel, Executive Director, Genetics Policy Institute
  • Jay Siegel, M.D., Chief Biotechnology Officer and Head, Scientific Strategy and Policy, Johnson & Johnson
  • Donna Skerrett, M.D., Chief Medical Officer, Mesoblast Ltd.
  • David Smith, Head, Cell Therapy Manufacturing, Lonza
  • Devyn Smith, Ph.D., Head of Strategy for Pharmatherapeutics, Worldwide R&D, Pfizer
  • Susan Solomon, Co-founder and CEO, New York Stem Cell Foundation (NYSCF)
  • Doris Taylor, Ph.D., Director, Regenerative Medicine Research; Director, Center for Cell and Organ Biotechnology, Texas Heart Institute
  • Keith Thompson, CEO, Cell Therapy Catapult
  • Gil Van Bokkelen, Ph.D., Chairman and CEO, Athersys, Inc.
  • Alexander Vos, CEO, PharmaCell B.V.

About The Alliance for Regenerative Medicine

The Alliance for Regenerative Medicine (ARM) is an international multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine worldwide. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations. Prior to the formation of ARM in 2009, there was no advocacy organization operating in Washington, DC to specifically represent the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today, ARM has more than 200 members and is the leading global advocacy organization in this field. To learn more about ARM or to become a member, visit http://www.alliancerm.org .

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/11/prweb12312328.htm

Linnden Communications Michelle Linn +1 (774) 696-3803

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sokin’s UAE License Turns Expansion Into Real Payments Plumbing

Updated Category News Views 97

Dubai expansion headlines are cheap; regulated local money movement is not. That is why Sokin’s newly approved Dubai Financial Services Authority license deserves more than the usual fintech applause line. The company has paired that approval with AED accounts, local payment rails, a One Za’abeel office and a plan to double its UAE staff over the next year. None of...

Continue Reading
Marelli’s Two Awards Put Practical Auto Tech in Focus

Updated Category News Views 43

Two trophies in Novi do not fill an order book, but Marelli’s latest pair says something useful about where automotive suppliers are trying to earn their keep. The company collected a 2026 Automotive News PACE Award for HorizonView and a PACE Pilot Award for Affordable 5G RedCap at the November 17 ceremony. One is already deployed in production; the other is a...

Continue Reading
LONGi's Solar-Storage Push Faces Africa's Cost Wall

Updated Category News Views 75

A vaccine refrigerator humming through a blackout is more meaningful than another climate-conference slogan. That was the useful thread running through LONGi's November 13 COP31 side event in Antalya, Türkiye: solar and storage are not merely hardware for remote communities. When designed, financed and maintained properly, they can keep clinics, water pumps and other...

Continue Reading
Sysco's Northern California Labor Deal Gets Bigger

Updated Category News Views 0

One hundred forty-four drivers may not rattle a giant food distributor by themselves, but labor agreements have a habit of growing legs. Sysco's Northern California and Nevada regional contract has added members from Teamsters Locals 386 and 431, bringing its coverage above 1,100 workers. For investors watching Sysco, this is less about one afternoon's headline and more...

Continue Reading
Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 116

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
Precision Metal Forming Is Industry's Quiet Backbone

Updated Category News Views 72

A fraction of a millimeter can turn a perfectly good industrial part into an expensive headache. That unglamorous reality sits at the center of Michele Caulfield's discussion of precision metal forming for HelloNation, and it deserves more attention than it usually gets. Investors watching manufacturing tend to chase flashy automation headlines, big aerospace orders, or...

Continue Reading
Envision and Tai Tam Put 45 MW Wind Bet to Work in Vietnam

Updated Category News Views 177

A wind site averaging 6.5 meters per second can look unremarkable on a map, yet that is precisely where equipment choices start separating serious developers from brochure merchants. Envision Energy and Vietnam's Tai Tam Group are taking that test on with the 45 MW Phuoc Dan wind project in Khanh Hoa Province. The arrangement follows five years of cooperation, but the...

Continue Reading
Three Cash Buyouts Draw Fresh Shareholder Scrutiny

Updated Category News Views 149

Three cash-price tags landed on the tape with a lawyerly asterisk attached: are public holders actually getting a fair shake? On November 18, 2026, Halper Sadeh LLC said it was investigating proposed sales involving Surgery Partners, Braze and CCC Intelligent Solutions. That is not a finding of misconduct, and investors ought to keep that distinction bolted firmly to the...

Continue Reading
Marina del Rey's Travel Award Brings Fresh Attention

Updated Category News Views 39

A harbor town just got handed a useful little megaphone. On November 18, 2026, the Marina del Rey Tourism Board said Marina del Rey had been selected as a winner in Good Housekeeping's 2027 Travel Awards. That is not a quarterly earnings event, and nobody ought to dress it up as one. Still, in the visitor economy, recognition from a broad consumer publication can matter...

Continue Reading
Berlin Heals Puts Microcurrent Therapy to a Real Test

Updated Category News Views 34

A silent electrical signal is heading into the sort of trial that separates intriguing ideas from credible medical evidence. Berlin Heals Holding AG has initiated C-MIC IV, an international randomized, double-blind, sham-controlled study of its implanted microcurrent therapy for symptomatic heart failure. The first patient has already been implanted in Kragujevac, Serbia....

Continue Reading

Top 5 Most Recently Viewed Articles

Tecsys Applauds 2026 Supply Chain Trailblazers

Updated Category News Views 26

Celebrating Supply Chain Game-Changers Diving headfirst into the world of supply chains at Tecsys's signature event, the User Conference in Nashville, showcased this year's champions who took the bull by the horns. These aren’t mere button pushers. They’re the powerhouses of healthcare and distribution, pushing operational performance to new heights. Driving Supply...

Continue Reading
Key Insights on Icelandic Salmon's Upcoming Q2 Results Webinar

Updated Category News Views 129

Exciting Presentation of Icelandic Salmon's Q2 Results Icelandic Salmon is gearing up to unveil its second quarter results for 2025. This exciting upcoming event is slated to take place on a Thursday via a Teams webinar, providing a platform for a detailed overview of the company's performance. Details of the Presentation Hosted by the esteemed CEO Bjørn Hembre alongside...

Continue Reading
TRG Screen Launches Xmon AI Assist for Enhanced Data Insights

Updated Category News Views 225

Revolutionizing Data Management with AI Technology In today's fast-paced financial landscape, organizations are constantly seeking tools that streamline operations and enhance decision-making capabilities. TRG Screen has risen to the occasion with the introduction of Xmon AI Assist, a cutting-edge innovation designed to transform how financial institutions manage their...

Continue Reading
Crypto Analyst Raoul Pal Discusses the Current Banana Zone Trends

Updated Category News Views 379

Raoul Pal’s Insights on the Current Crypto Market U.Today - Raoul Pal, the founder and CEO of Real Vision, is widely recognized for his expertise in cryptocurrency and investing. Recently, he took to the social media platform X (formerly known as Twitter) to engage with his followers about the prevailing conditions in the crypto market and the future outlook for...

Continue Reading
Investing $1000 in Gold Fields: A 5-Year Growth Journey

Updated Category News Views 230

The Incredible Return on Gold Fields Investment Gold Fields (NYSE: GFI) has remarkably outperformed the market in the past five years, showcasing an annualized return of 27.98%—a substantial difference over standard investment returns. With a current market capitalization of $38.14 billion, Gold Fields stands out as a worthwhile investment opportunity. What If You...

Continue Reading